JCAR014 and Durvalumab in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Name: JCAR014 and Durvalumab in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
License: Public Domain

Fred Hutchinson Cancer Center

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

diffuse large b-cell lymphoma, not otherwise specified, recurrent diffuse large b-cell lymphoma, recurrent primary mediastinal (thymic) large b-cell lymphoma, refractory diffuse large b-cell lymphoma, refractory high grade b-cell lymphoma with myc, bcl2, and bcl6 rearrangements, refractory primary mediastinal (thymic) large b-cell lymphoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 474753
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.